A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)
Alza Corporation, DE, USA
The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine
conditions and obtain a more comprehensive understanding of the safety of the system and
complications that may not be spontaneously reported.
Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects
This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic
study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL
inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device
administered in normal healthy non-smoking subjects.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.